Quinacrine: New anti-tumor application for an old anti-malaria drug.
Mollapour
Mehdi
M
Neckers
Len
L
D000962:Antimalarials / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D004268:DNA-Binding Proteins / Q000378:metabolism; D000076249:Heat Shock Transcription Factors; D006360:Heat-Shock Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism; D006801:Humans; D061965:Matrix Metalloproteinase Inhibitors; D020782:Matrix Metalloproteinases / Q000378:metabolism; D011796:Quinacrine / Q000494:pharmacology*; D014157:Transcription Factors / Q000378:metabolism; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism
D000962:Antimalarials; D000970:Antineoplastic Agents; D004268:DNA-Binding Proteins; D000076249:Heat Shock Transcription Factors; D006360:Heat-Shock Proteins; D061965:Matrix Metalloproteinase Inhibitors; D014157:Transcription Factors; D016159:Tumor Suppressor Protein p53; D020782:Matrix Metalloproteinases; D011796:Quinacrine